Have a personal or library account? Click to login
Functionality evaluation of co-processed excipients as diluents in tablets manufactured by wet granulation Cover

Functionality evaluation of co-processed excipients as diluents in tablets manufactured by wet granulation

Open Access
|Jan 2021

References

  1. Abdallah DB, Charoo NA, Elgorashi AS. Comparative binding and disintegrating property of Echinochloa colona starch (difra starch) against maize, sorghum, and cassava starch. Pharm Biol. 2014; 52:935–943.
  2. Adjei FK, Osei YA, Kuntworbe N, Ofori-kwakye K. Evaluation of the disintegrant properties of native starches of five new cassava varieties in paracetamol tablet formulations. J Pharm. 2017:1–9
  3. Apeji Y, Oyi A., Hassan M. Formulation and evaluation of ascorbic acid tablets by direct compression using microcystalline starch as a direct compression excipient. Int J Heal Res. 2011; 4:113–118
  4. Chaerunisaa AY, Sriwidodo S, Abdassah M. Microcrystalline cellulose as pharmaceutical excipient. In: Pharmaceutical Formulation Design - Recent Practices. IntechOpen, 2019, pp 1–22
  5. Choudhari PK, Jain HK, Sharma P, Srivastava B. A novel co-processed directly compressible release-retarding polymer: In vitro, solid state and in vivo evaluation. Futur J Pharm Sci. 2018; 4:29–40.
  6. Daraghmeh N, Chowdhry B, Leharne S, Omari M, Badwan A. Co-processed chitin-mannitol as a new excipient for oro-dispersible tablets. Mar Drugs. 2015; 13:1739–1764.
  7. Daraghmeh N, Rashid I, Al Omari MMH, Leharne SA, Chowdhry BZ, Badwan A. Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol. AAPS PharmSciTech. 2010; 11:1558–1571.
  8. Dong QQ, Zhou MM, Lin X, Shen L, Feng Y. Differences in fundamental and functional properties of HPMC co-processed fillers prepared by fluid-bed coating and spray drying. Eur J Pharm Sci. 2018; 119:147–158.
  9. Edge S, Steele DF, Chen A, Tobyn MJ, Staniforth JN. The mechanical properties of compacts of microcrystalline cellulose and silicified microcrystalline cellulose. Int J Pharm. 2000; 200:67–72.
  10. Fell J, Newton J. Determination of tablet strength by the diametral-compression test. J Pharm Sci. 1970; 59:688–691
  11. Joiris E, Di Martino P, Berneron C, Guyot-Hermann A, Guyot J. Compression behavior of orthorhombic paracetamol. Pharm Res. 1998; 15:1122–1130
  12. Nachaegari SK, Bansal AK. Coprocessed excipients for solid dosage forms. Pharm Technol. 2004; 28:52–64
  13. Nguyen TH, Morton DAV, Hapgood KP. Predicting tablet strength from the wet granulation conditions via the unified compaction curve. Procedia Engineering. 2015; 102:517–526.
  14. Ohwoavworhua FO, Adelakun TA. Non-wood fibre production of microcrystalline cellulose from Sorghum caudatum: characterisation and tableting properties. Indian J Pharm Sci. 2010; 72:295–301
  15. Olayemi O, Oyi A, Allagh T. Comparative evaluation of maize, rice and wheat starch powders as pharmaceutical excipients. Nig J Pharm Sci. 2008; 7:131–138
  16. Osamura T, Takeuchi Y, Onodera R, et al. Formulation design of granules prepared by wet granulation method using a multi-functional single-punch tablet press to avoid tableting failures. Asian J Pharm Sci. 2018; 13:113–119.
  17. Osei-Yeboah F, Feng Y, Sun CC. Evolution of structure and properties of granules containing microcrystalline cellulose and polyvinylpyrrolidone during high-shear wet granulation. J Pharm Sci. 2014; 103:207–215.
  18. Pilpel N. Flow properties of non-cohesive powders. Chem Proc Eng. 1965 46:167
  19. Sonnergaard JM. Quantification of the compactibility of pharmaceutical powders. Eur J Pharm Biopharm. 2006; 63:270–277.
  20. Sun CC. Microstructure of tablet — pharmaceutical significance, assessment, and engineering. Pharm Res. 2017; 34:918–928.
  21. Sun CC. Decoding powder tabletability: roles of particle adhesion and plasticity. J Adhes Sci Technol. 2011; 25:483–499.
  22. Sun CC. Quantifying effects of moisture content on flow properties of microcrystalline cellulose using a ring shear tester. Powder Technol. 2016; 289:104–108.
  23. United States Pharmacopeial Convention. USP protocol for dissolution studies. In: USP/NF, 2011.
  24. United States Pharmacopoeial Convention. USP protocol for bulk and tapped densities. In: USP/NF, 2012.
  25. Upadhyay P, Khomane KS, Kumar L, Bansal AK. Relationship between crystal structure and mechanical properties of ranitidine hydrochloride polymorphs. CrystEngComm. 2013; 15:3959–3964.
  26. Wang S, Li J, Lin X, et al. Novel coprocessed excipients composed of lactose, HPMC, and PVPP for tableting and its application. Int J Pharm. 2015; 486:370–379.
  27. Yadav JA, Khomane KS, Modi SR, et al. Correlating single crystal structure, nanomechanical, and bulk compaction behavior of febuxostat polymorphs. Mol Pharm. 2017; 14:866–874.
  28. Zeitler J, Rades T. Interdependence of dosage form microstructure and performance. Pharm Res. 2017: 1–3.
  29. Zhang J, Wu C, Pan X, Wu C. On identification of critical material attributes for compression behaviour of pharmaceutical diluent powders. Materials (Basel). 2017; 10:1–16.
  30. British Pharmacopoeia, Volume II. Her Majesty's Stationery Office, London, UK, 2013.
Language: English
Page range: 5 - 14
Submitted on: Jul 29, 2020
|
Accepted on: Jan 8, 2020
|
Published on: Jan 29, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2021 Y. Eshovo Apeji, IY. Muhammad, A. Kehinde Olowosulu, G. Owoicho Okpanachi, A. Rukayat Oyi, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.